MEDICINOVA INC — Investor Relations & Filings
MediciNova Inc. is a biopharmaceutical company focused on developing novel small molecule therapeutics for serious diseases with unmet medical needs. Its pipeline targets neurology, respiratory, and liver diseases. Key product candidates include MN-166 (ibudilast), which is being developed for indications such as Amyotrophic Lateral Sclerosis (ALS), Progressive Multiple Sclerosis, Oncology/Glioblastoma, Chemotherapy-Induced Peripheral Neuropathy (CIPN), and Acute Respiratory Distress Syndrome (ARDS)/Lung Injury. MN-166 has also been marketed in Japan and Korea for post-stroke complications and bronchial asthma. Another candidate, MN-001 (tipelukast), is in development for Non-Alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes Mellitus, and Hypertriglyceridemia. The company's mission involves acquiring and accelerating the global development and commercialization of these therapeutics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-14 | English | |
| ARS | 2026-04-29 | English | |
| DEFA14A | 2026-04-29 | English | |
| DEF 14A | 2026-04-29 | English | |
| PRER14A | 2026-04-20 | English | |
| PRE 14A | 2026-04-17 | English |
Browse filings by year
3 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 46722291 | 10-Q | 2026-05-14 | English | ||
| 46722292 | ARS | 2026-04-29 | English | ||
| 46722293 | DEFA14A | 2026-04-29 | English | ||
| 46722295 | DEF 14A | 2026-04-29 | English | ||
| 46722297 | PRER14A | 2026-04-20 | English | ||
| 46722298 | PRE 14A | 2026-04-17 | English | ||
| 46722305 | 10-K | 2026-03-10 | English | ||
| 46722300 | 8-K | 2026-02-20 | English | ||
|
2025
7 filings
| |||||
| 46722307 | 424B5 | 2025-12-30 | English | ||
| 46722309 | 8-K | 2025-12-30 | English | ||
| 46722311 | Regulatory Filings 2025 | 2025-12-12 | English | ||
| 46722313 | S-3 | 2025-12-05 | English | ||
| 46722317 | 10-Q | 2025-11-12 | English | ||
| 46722318 | Regulatory Filings 2025 | 2025-10-01 | English | ||
| 46722321 | S-1 | 2025-08-22 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Amylyx Pharmaceuticals, Inc.
Develops therapies for neurodegenerative diseases and other…
|
AMLX | US | Manufacturing |
|
AN2 Therapeutics, Inc.
Biopharmaceutical firm developing boron-based drugs for inf…
|
ANTX | US | Manufacturing |
|
Ananda Pharma Plc
Biopharmaceutical firm developing cannabinoid-based medicin…
|
ANAN | GB | Manufacturing |
|
ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.
Designs, develops, and manufactures molecular diagnostic so…
|
ANGEN | TR | Manufacturing |
|
ANAVEX LIFE SCIENCES CORP.
Clinical-stage biopharmaceutical company developing therape…
|
AVXL | US | Manufacturing |
|
Anbio Biotechnology
Develops and provides in-vitro diagnostic (IVD) solutions a…
|
NNNN | KY | Manufacturing |
|
Anebulo Pharmaceuticals, Inc.
Clinical-stage biotech developing therapies for acute canna…
|
ANEB | US | Manufacturing |
|
AnGes, Inc.
Biopharmaceutical firm developing gene-based and nucleotide…
|
4563 | JP | Manufacturing |
|
ANG Lifesciences India Limited
Develops and manufactures sterile dry powder and liquid inj…
|
540694 | IN | Manufacturing |
|
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD.
Develops biopharmaceuticals, genetic engineering products, …
|
300009 | CN | Manufacturing |
MEDICINOVA INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72582/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72582 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72582 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72582 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72582}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MEDICINOVA INC (id: 72582)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.